Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
Ankylosing Spondylitis (AS) is a common inflammatory rheumatic disease with a predilection for the axial skeleton, affecting 0.2% of the population. Current diagnostic criteria rely on a composite of clinical and radiological changes, with a mean time to diagnosis of 5 to 10 years. In this study we...
Auteurs principaux: | Fischer, R, Trudgian, D, Wright, C, Thomas, G, Bradbury, L, Brown, M, Bowness, P, Kessler, B |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
MASS SPECTROMETRY-BASED DETECTION AND QUANTITATION OF PUTATIVE BIOMARKERS FOR ANKYLOSING SPONDYLITIS
par: Fischer, R, et autres
Publié: (2011) -
A proteomic approach to the identification of marker proteins for ankylosing spondylitis and rheumatoid arthritis
par: Wright, C, et autres
Publié: (2005) -
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis
par: Mark Hwang, et autres
Publié: (2023-04-01) -
Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.
par: Wright, C, et autres
Publié: (2010) -
Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.
par: Wright, C, et autres
Publié: (2012)